Quinten identifies a combination of two synergistic markers that predicts a favorable response to treatment in breast cancer
27-Feb-2013 -
Quinten announced the identification of two discriminating biological marker candidates which are indicative of a favorable response to treatment in women suffering from triple-negative breast cancer (TNBC). In the sub-group with both markers in combination, 86 per cent of women responded to ...
breast cancer
cancer